ENCell Co Ltd

0
XKRX:456070 (Korea (the Republic of))   Ordinary Shares
â‚© 23350.00 (-1.48%) Oct 23
At Loss
P/B:
3.85
Market Cap:
â‚© 218.32B ($ 158.27M)
Enterprise V:
â‚© 206.21B ($ 149.49M)
Volume:
1.35M
Avg Vol (2M):
5.21M
Trade In:
Volume:
1.35M
At Loss

Business Description

ENCell Co Ltd

ISIN : KR7456070002

Share Class Description:

XKRX:456070: Ordinary Shares
Compare
Compare
Traded in other countries / regions
456070.Korea
IPO Date
2024-08-23
Description
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.
Name Current Vs Industry Vs History
Cash-To-Debt 4.23
Equity-to-Asset 0.86
Debt-to-Equity 0.12
Debt-to-EBITDA 3.96
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 21.51
Distress
Grey
Safe
Beneish M-Score -3.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -39.3
3-Year EPS without NRI Growth Rate 48.1
3-Year FCF Growth Rate 47.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 54.87
9-Day RSI 54.18
14-Day RSI 54.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.36
Quick Ratio 7.85
Cash Ratio 6.81
Days Inventory 58.88
Days Sales Outstanding 49.21
Days Payable 4.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -222.6
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ENCell Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 10,525.887
EPS (TTM) (â‚©) -818
Beta 0
Volatility % 0
14-Day RSI 54.62
14-Day ATR (â‚©) 2867.488119
20-Day SMA (â‚©) 21924.5
12-1 Month Momentum % 0
52-Week Range (â‚©) 16740 - 45800
Shares Outstanding (Mil) 9.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ENCell Co Ltd Filings

Filing Date Document Date Form
No Filing Data

ENCell Co Ltd Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

ENCell Co Ltd Frequently Asked Questions

What is ENCell Co Ltd(XKRX:456070)'s stock price today?
The current price of XKRX:456070 is â‚©23350.00. The 52 week high of XKRX:456070 is â‚©45800.00 and 52 week low is â‚©16740.00.
When is next earnings date of ENCell Co Ltd(XKRX:456070)?
The next earnings date of ENCell Co Ltd(XKRX:456070) is .
Does ENCell Co Ltd(XKRX:456070) pay dividends? If so, how much?
ENCell Co Ltd(XKRX:456070) does not pay dividend.

Press Release

Subject Date
No Press Release